| Title |
Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda
|
|---|---|
| Published in |
PLOS ONE, February 2012
|
| DOI | 10.1371/journal.pone.0030735 |
| Pubmed ID | |
| Authors |
Joseph B. Babigumira, Andy Stergachis, David L. Veenstra, Jacqueline S. Gardner, Joseph Ngonzi, Peter Mukasa-Kivunike, Louis P. Garrison |
| Abstract |
Over two thirds of women who need contraception in Uganda lack access to modern effective methods. This study was conducted to estimate the potential cost-effectiveness of achieving universal access to modern contraceptives in Uganda by implementing a hypothetical new contraceptive program (NCP) from both societal and governmental (Ministry of Health (MoH)) perspectives. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| Belgium | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 153 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 35 | 22% |
| Researcher | 31 | 20% |
| Student > Ph. D. Student | 18 | 11% |
| Student > Doctoral Student | 11 | 7% |
| Student > Bachelor | 10 | 6% |
| Other | 29 | 18% |
| Unknown | 23 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 31% |
| Social Sciences | 32 | 20% |
| Nursing and Health Professions | 16 | 10% |
| Economics, Econometrics and Finance | 14 | 9% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Other | 16 | 10% |
| Unknown | 26 | 17% |